4-Bromoamphetamine Stats & Data

Rationale for additions (harm reduction): Para-halogenated amphetamines such as p-chloroamphetamine are used as serotonergic neurotoxins in animal research; community moderators and chemistry-focused users warn that 4-BA is analogous and likely neurotoxic, so conservative guidance treats it as a high-risk agent with poor recreational value; therefore, the safest advice is avoidance or, failing that, very cautious titration with no redosing. Reagent kits are not sufficient to characterize 4-BA; if a sample is suspected, submit to a mass-spectrometry drug checking service where available; these services publish ongoing findings and are designed to help people make safer choices. Mixing with MAOIs, SSRIs/SNRIs, tramadol, DXM, triptans, methylene blue, or other serotonergic agents can precipitate dangerously elevated serotonin and autonomic instability; TripSit’s combinations guidance supports avoiding serotonergic-stimulant + antidepressant/MAOI stacks. Even plain amphetamines raise heart rate, blood pressure, and body temperature; overheating and dehydration increase risk with any stimulant, so active cooling, spacing doses, and electrolyte-containing fluids are advised; TripSit’s amphetamine factsheets (e.g., Adderall/Vyvanse) emphasize tachycardia, hypertension, dehydration, and hyperthermia risks. Intranasal use can spike plasma levels and may increase neurotoxic and cardiovascular stress relative to cautious oral dosing; oral-only is the least risky ROA if someone does not abstain. This general ROA principle is reflected across harm-reduction communities and TripSit resources. Because validated human pharmacokinetics are lacking, any stated duration and dosing should be treated as uncertain; community posts about 4-BA focus on neurotoxicity and advise against use rather than providing reliable dosing, reinforcing that there is no ‘established’ safe dose. Cardiac strain and vasoconstriction concerns suggest those with cardiovascular disease, hypertension, or on QT-prolonging/pressors should avoid entirely; stimulant HR pages highlight these effects for amphetamines generally. Post-acute low mood, anxiety, and sleep disruption are plausible due to serotonergic and catecholaminergic depletion; community warnings specifically mention prolonged 5-hydroxyindole depletion after exposure to para-halogenated amphetamines. If a vendor is offering 4-BA/4-CMA, community advisories recommend warning others and not stocking/using; some vendors have been called out for listing such neurotoxins recently, increasing the risk of mis-selling into stimulant markets.